6Q1 Stock Overview
Provides software solutions for healthcare sector in Norway, Sweden, Denmark, Finland, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Omda AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 4.69 |
| 52 Week High | NOK 4.69 |
| 52 Week Low | NOK 2.22 |
| Beta | 0.55 |
| 1 Month Change | 42.12% |
| 3 Month Change | 54.28% |
| 1 Year Change | 62.85% |
| 3 Year Change | -1.47% |
| 5 Year Change | n/a |
| Change since IPO | -42.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6Q1 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 33.6% | 3.8% | 0.8% |
| 1Y | 62.8% | 10.1% | 15.0% |
Return vs Industry: 6Q1 exceeded the German Healthcare Services industry which returned 10.3% over the past year.
Return vs Market: 6Q1 exceeded the German Market which returned 14.4% over the past year.
Price Volatility
| 6Q1 volatility | |
|---|---|
| 6Q1 Average Weekly Movement | 12.6% |
| Healthcare Services Industry Average Movement | 6.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in DE Market | 12.8% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: 6Q1's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 6Q1's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 268 | Sverre Flatby | www.omda.com |
Omda AS provides software solutions for healthcare sector in Norway, Sweden, Denmark, Finland, and internationally. It offers laboratory information management systems consist of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology treatment management solution. The company also provides connected healthcare solutions, including Omda Cardio, an ECG and diagnostic storage tool; Omda CIMA, a medical imaging mobile app; Omda Media, a web-based medical imaging solution; Omda Medimaker, an image management and workflow; Omda Picsara, an image management solution; Omda Arcidis, an integrated teleradiology system; Omda Helsemail, an patient data transfer tool; Omda Plutus, audit and workflow monitoring platform; Omda S7, a secure e-care communications platform; and Omda XDS, patient data storage and management solution.
Omda AS Fundamentals Summary
| 6Q1 fundamental statistics | |
|---|---|
| Market cap | €88.85m |
| Earnings (TTM) | -€3.94m |
| Revenue (TTM) | €38.16m |
Is 6Q1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6Q1 income statement (TTM) | |
|---|---|
| Revenue | NOK 442.14m |
| Cost of Revenue | NOK 267.56m |
| Gross Profit | NOK 174.58m |
| Other Expenses | NOK 220.22m |
| Earnings | -NOK 45.64m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 29, 2025
| Earnings per share (EPS) | -2.23 |
| Gross Margin | 39.48% |
| Net Profit Margin | -10.32% |
| Debt/Equity Ratio | 1,484.7% |
How did 6Q1 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/19 19:25 |
| End of Day Share Price | 2025/05/19 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Omda AS is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristian Støle | Carnegie Investment Bank AB |
| Emilie Engen | DNB Markets |